Oncology

Oncology covers companies developing therapies, diagnostics, and enabling technologies for cancer. On BioPharmSignal, this sector page groups businesses tied to solid tumors, hematologic malignancies, precision oncology, immuno-oncology, and other cancer-focused programs.

Why watch Oncology

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Oncology news

The latest feed items from companies currently grouped under Oncology.

1. 01
   2026-09-20 10:00 EST

   CUECue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria

   Source: Cue Biopharma Inc

2. 02
   2026-09-18 21:10 EST

   IOVAIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

   Source: Iovance Biotherapeutics, Inc.

3. 03
   2026-09-18 20:32 EST

   TEVANew Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

   Source: Teva Pharmaceutical Industries

4. 04
   2026-09-18 20:31 EST

   TEVATeva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

   Source: Teva Pharmaceutical Industries

5. 05
   2026-09-18 20:30 EST

   TEVATeva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

   Source: Teva Pharmaceutical Industries

6. 06
   2026-09-18 20:01 EST

   GERNGeron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: Geron

7. 07
   2026-09-17 20:57 EST

   LIXTNOMAD POWER SOLUTIONS FILES EXPANDED BUSINESS AND FINANCIAL DISCLOSURE FOLLOWING COMPLETION OF MERGER

   Source: Lixte Biotechnology Holdings

8. 08
   2026-09-17 20:03 EST

   ARGXargenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

   Source: Argenx

9. 09
   2026-09-17 13:27 EST

   LSTALisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement

   Source: Lisata Therapeutics

10. 10
    2026-09-17 12:00 EST

    BIAFbioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic

    Source: bioAffinity Technologies, Inc.

11. 11
    2026-09-17 11:30 EST

    FENCFennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

    Source: Fennec Pharmaceuticals Inc.

12. 12
    2026-09-17 11:00 EST

    TLSATiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center

    Source: Tiziana Life Sciences

13. 13
    2026-09-17 10:30 EST

    AEMDAethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis

    Source: Aethlon Medical

14. 14
    2026-09-16 19:26 EST

    IPHAInnate Pharma reports first half 2026 business update and financial results

    Source: Innate Pharma

15. 15
    2026-09-16 16:53 EST

    IPHAInnate and Sobi announce partnership is now effective following completion of closing conditions

    Source: Innate Pharma

16. 16
    2026-09-16 12:15 EST

    MKTMAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial

    Source: Maia Biotechnology

17. 17
    2026-09-16 12:00 EST

    TEVATeva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care

    Source: Teva Pharmaceutical Industries

18. 18
    2026-09-16 11:30 EST

    ARTLArtelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

    Source: Artelo Biosciences

19. 19
    2026-09-16 11:00 EST

    FATEFate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026

    Source: Fate Therapeutics

20. 20
    2026-09-16 11:00 EST

    XBIOXenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics

    Source: Xenetic

Companies in Oncology

294 companies tagged with Oncology.

Frequently Asked Questions